"Several promising candidates have been
identified during the screening process, which
is expected to conclude within two months.
Genentech will then have up to 12 months to
evaluate results before deciding whether to
licence or extend its option over the peptides.
In either case Phylogica would be eligible to
receive a significant milestone payment."
LICENSE OR EXTEND- in EITHER case a milestone payment. So Jack shoot it either case doesn't eventuate.
PYC Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)